Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA approves treatment for homocystinuria

Nov. 19, 1996

NIH awards grant for gene therapy approach to improving cancer treatment

Nov. 19, 1996

Astra claims orally active peptide immunomodulators

Nov. 19, 1996

ET antagonists revealed by SmithKline Beecham

Nov. 19, 1996

EGFR tyrosine kinase inhibitors described by Pfizer

Nov. 19, 1996

RPR claims taxoid antineoplastic compounds

Nov. 19, 1996

Growth stimulant reported by American Cyanamid

Nov. 19, 1996

ProCyte copper-based compound associated with improvement in ulcerative colitis

Nov. 19, 1996

Hirudin-based thrombin inhibitors reported by Canadian investigators

Nov. 19, 1996

Clinical results with Seragen fusion toxin in psoriasis

Nov. 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...